Tanzania Pharmaceuticals and Healthcare Report Q2 2013
3/13/2013 | published by: Business Monitor International
... is a market heavily reliant on imports, which bear the greatest risk of counterfeitmedication. Combined with the discovery of a production facility producing fake drugs, this has led BMI to believe theroad to the availability ...
|
read more...
|
$1,175.00
|
Tanzania Pharmaceuticals and Healthcare Report Q1 2013
12/12/2012 | published by: Business Monitor International
... increase. However, we are concerned by the continued reliance onforeign grants and concessional loans. Headline Expenditure Projections Pharmaceuticals: TZS340.1bn (US$214mn) in 2011 to an expected TZS406.0bn(US$257mn) in 2012; +19.4% growth in local currency terms and ...
|
read more...
|
$1,175.00
|
Spectacle Frame and Mounting Market in Tanzania
10/15/2012 | published by: Global Research & Data Services
... for spectacle frames and mountings in Tanzania Overall market volume for spectacle frames and mountings in Tanzania Market value and volume for spectacle frames and mountings by type Product prices Forecasts and future outlook of ...
|
read more...
|
$633.00
|
Spectacle Lense Market in Tanzania
10/15/2012 | published by: Global Research & Data Services
... lenses in Tanzania Overall market volume for spectacle lenses in Tanzania Market value and volume for spectacle lenses by type Product prices Forecasts and future outlook of the market Country overview, macroeconomic indicators and indicators ...
|
read more...
|
$633.00
|
Tanzania Pharmaceuticals and Healthcare Report Q4 2012
8/21/2012 | published by: Business Monitor International
... for a disease class that is a growing burden on the country's healthcare system. Additionally, we have previously highlighted our concern over the country's continued reliance on foreign grants and concessional loans, so it is ...
|
read more...
|
$1,175.00
|
Tanzania Pharmaceuticals and Healthcare Report Q3 2012
5/8/2012 | published by: Business Monitor International
... particularly as reports have highlighted the poor availability of essential medicines in the country. Furthermore, we believe the investment in improving the medicine procurement process will increase Tanzania's attractiveness as a location in which to ...
|
read more...
|
$1,175.00
|
Analysis of the Pharmaceutical Market of Kenya and Tanzania
4/20/2012 | published by: Frost & Sullivan
... and private sectors to the total industry value; quantifies and forecasts segment revenue contribution from 2008 to 2016; and provides insight into the key challenges, drivers, and restraints. Further, it provides a competitor analysis of ...
|
read more...
|
$6,000.00
|
The Pharmaceutical Industry in Key East African Countries
6/1/2010 | published by: Frost & Sullivan
... indicates the contribution from the public- and private sectors to the total industry value. The research service also quantifies and forecasts the revenue contribution of each therapeutic segment towards the total pharmaceutical industry from 2009 ...
|
read more...
|
$7,500.00
|
The Medical Imaging Market in Tanzania
7/23/2009 | published by: Frost & Sullivan
... forecasts are provided and industry best practices are discussed. Current industry challenges, market drivers and restraints are highlighted and a thorough competitor analysis is provided. This service concludes with strategic recommendations for existing and potential ...
|
read more...
|
$7,500.00
|
Strategic Analysis of the Healthcare Industry in Tanzania
1/7/2009 | published by: Frost & Sullivan
... key industry dynamics affecting each of pharmaceuticals and medical devices is presented, as well as industry sizes and growth rates over the period 2007-2014. In addition, a thorough competitor analysis for each industry was performed.
|
read more...
|
$7,500.00
|
Key Sub-Saharan African Infectious Disease Pharmaceutical Markets
2/25/2008 | published by: Frost & Sullivan
... research, Frost & Sullivan's expert analysts thoroughly examine the following markets: HIV, TB and Malaria. This analysis is available through our Pharmaceuticals and Biotechnology Growth Partnership Services programme. With this programme, clients receive industry-leading market ...
|
read more...
|
$6,000.00
|
|
|
$6,000.00
|
|
|
$6,000.00
|
|
|
$6,500.00
|
|
|
$6,750.00
|